Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for Acute Gastrointestinal Injury
NCT04934904Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in Gastrointestinal injury (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoints: The cure rate of Acute Gastrointestinal Injury at Day 7 and The remission rate of Acute Gastrointestinal Injury at Day 7. Started Aug 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
Gastrointestinal injury
Beyond the preview
Go deeper on NCT04934904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04934904.